维百奥(北京)生物科技有限公司

400-001-2615
info@vicbio.com
产品名称 ReVacc Scientific P40C22 | VSV-Pseudovirus_SARS-CoV-2 Omicron Strain BA.2 Spike with luciferase reporter
目录号 P40C22
别名 VSV-Pseudovirus_SARS-CoV-2 Omicron Strain BA.2 Spike with luciferase reporter
外观 见COA
分子量 N/A
CAS N/A
溶解度
存储条件 见COA
保存时间 见COA
备注1
备注2
目录号 规格 价格 库存状态  
P40C22 200 μl; 1000 μl 咨询 咨询


ReVacc Scientific P40C22 | VSV-Pseudovirus_SARS-CoV-2 Omicron Strain BA.2 Spike with luciferase reporter


品名:VSV-Pseudovirus_SARS-CoV-2 Omicron Strain BA.2 Spike with luciferase reporter

货号:P40C22

品牌:ReVacc Scientific

规格:200 μl; 1000 μl


产品描述

Organism:SARS-Related Coronavirus 2 (virus caused COVID-19), Omicron BA.2 variant.

This pseudotyped virus uses recombinant vesicular stomatitis virus (rVSV) to carry spike protein of SARS-CoV-2 (GenBank: MN908947) with multiple mutations initially identified in variant of Omicron BA.2, including: T19I, LPP24-26del, A27S, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, S477N, T478K, E484A, Q493R, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H, N969K. The spike protein has a 18-aa cytoplasmic tail truncation for optimal infection. As pseudovirus infectivity of rVSV without its original G is restricted to a single round of replication, the pseudotypes can be handled using BSL-2 containment practices. Infection of cells with this pseudotyped virus carrying luciferase reporter results in high level luciferase activity. See our titration result showing that the starting 2-fold diluted pseudovirus generates signal over 100,000-fold higher than uninfected control (cell alone as background in blue). We also evaluated the neutralizing activity of two published control mAbs and one own S2-specific antibody RV6 by using this pseudotyped virus with one (CB6) losing neutralizing activity against this variant. See figure.

相关产品